SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 539 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,579,275 | +251.8% | 648,500 | +219.1% | 2.12% | +206.1% |
| Q2 2023 | $39,107,872 | +28.8% | 203,200 | +35.5% | 0.69% | +17.9% |
| Q1 2023 | $30,370,500 | +78.6% | 150,000 | +20.7% | 0.59% | +149.8% |
| Q3 2022 | $17,008,000 | +99.9% | 124,300 | +158.5% | 0.24% | +99.2% |
| Q2 2022 | $8,509,000 | -26.6% | 48,089 | -40.2% | 0.12% | -15.1% |
| Q1 2022 | $11,586,000 | -44.5% | 80,410 | -40.4% | 0.14% | -40.6% |
| Q4 2021 | $20,872,000 | – | 135,000 | +13499900.0% | 0.23% | – |
| Q3 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q2 2021 | $19,236,000 | +43.2% | 121,835 | +26.0% | 0.25% | -12.8% |
| Q1 2021 | $13,429,000 | – | 96,700 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |